Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis (GAMES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03259282|
Recruitment Status : Completed
First Posted : August 23, 2017
Last Update Posted : April 12, 2018
|Condition or disease||Intervention/treatment|
|Sarcoidosis||Biological: Analysis of gamma globulin|
In 50% of cases, sarcoidosis is associated with polyclonal hypergammaglobulinemia. The other forms have a normal gamma globulin level.
The level of gamma globulinemia has not yet been studied as an evolutionary predictive factor. Furthermore, there are disseminated granulomatoses sharing common characteristics with sarcoidosis, associated with Common Variable Immunodeficiency deficit (DICV) type Primary Immunodeficiency syndrome (DIP), thus occurring in hypogammaglobulinemic patients.
|Study Type :||Observational|
|Actual Enrollment :||78 participants|
|Official Title:||Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis|
|Actual Study Start Date :||March 7, 2017|
|Actual Primary Completion Date :||March 22, 2017|
|Actual Study Completion Date :||March 22, 2017|
- Biological: Analysis of gamma globulin
Electrophoresis of proteins
- Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on disease activity [ Time Frame: Day 1 ]Electrophoresis rates of serum proteins
- Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on the course of the disease [ Time Frame: Day 1 ]Electrophoresis rates of serum proteins
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03259282
|CHU de Rennes|
|Rennes, France, 35033|